Jazz Pharmaceuticals JAZZ Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Jazz Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Jazz Pharmaceuticals's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Jazz Pharmaceuticals's total assets?
- Jazz Pharmaceuticals (JAZZ) reported total assets of $11.86B in Q1 2026.
- How has Jazz Pharmaceuticals's total assets changed year-over-year?
- Jazz Pharmaceuticals's total assets increased by 2.8% year-over-year, from $11.53B to $11.86B.
- What is the long-term trend for Jazz Pharmaceuticals's total assets?
- Over 5 years (2020 to 2025), Jazz Pharmaceuticals's total assets has grown at a 12.3% compound annual growth rate (CAGR), from $6.54B to $11.66B.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- Growth generally indicates business expansion or acquisition activity, while a decline may signal asset divestiture or significant impairment.
- How does total assets compare across companies?
- Standard metric used to compare company size and asset efficiency across the pharmaceutical sector.